Search

Author/Creator Boven, Epie

1. Adherence and patients' experiences with the use of oral anticancer agents. (February 2014)

Authors:
Timmers, Lonneke; Boons, Christel C. L. M.; Kropff, Femke; van de Ven, Peter M.; Swart, Eleonora L.; Smit, Egbert F.; Zweegman, Sonja; Kroep, Judith R.; Timmer-Bonte, Johanna N. H.; Boven, Epie; Hugtenburg, Jacqueline G.
Journal:
Acta oncologica
Issue:
Volume 53:Number 2(2014)
Page Start:
259
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Evaluation of KDR rs34231037 as a predictor of sunitinib efficacy in patients with metastatic renal cell carcinoma. Issue 6 (June 2017)

Authors:
Apellániz-Ruiz, María; Diekstra, Meta H.; Roldán, Juan M.; Boven, Epie; Castellano, Daniel; Gelderblom, Hans; Mathijssen, Ron H.J.; Swen, Jesse J.; Böhringer, Stefan; García-Donás, Jesús; Rini, Brian I.; Guchelaar, Henk-Jan; Rodríguez-Antona, Cristina
Journal:
Pharmaocogenetics and genomics
Issue:
Volume 27:Issue 6(2017:Jun.)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. High ctDNA molecule numbers relate with poor outcome in advanced ER+, HER2− postmenopausal breast cancer patients treated with everolimus and exemestane. Issue 3 (7th February 2020)

Authors:
Kruger, Dinja T.; Jansen, Maurice P.H.M.; Konings, Inge R.H.M.; Dercksen, Wouter M.; Jager, Agnes; Oulad Hadj, Jamal; Sleijfer, Stefan; Martens, John W.M.; Boven, Epie
Journal:
Molecular oncology
Issue:
Volume 14:Issue 3(2020)
Page Start:
490
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. IGF‐1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER‐positive breast cancer. Issue 8 (6th October 2019)

Authors:
Kruger, Dinja T.; Alexi, Xanthippi; Opdam, Mark; Schuurman, Karianne; Voorwerk, Leonie; Sanders, Joyce; van der Noort, Vincent; Boven, Epie; Zwart, Wilbert; Linn, Sabine C.
Journal:
International journal of cancer
Issue:
Volume 146:Issue 8(2020)
Page Start:
2348
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Single-nucleotide polymorphisms in the genes of CES2, CDA and enzymatic activity of CDA for prediction of the efficacy of capecitabine-containing chemotherapy in patients with metastatic breast cancer. (February 2018)

Authors:
Lam, Siu W.; van der Noort, Vincent; van der Straaten, Tahar; Honkoop, Aafke H.; Peters, Godefridus J.; Guchelaar, Henk-Jan; Boven, Epie
Journal:
Pharmacological research
Issue:
Volume 128(2018)
Page Start:
122
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗